USMeds Pedigree Systems

What USMeds Pedigree Systems does

USMeds Pedigree Systems (legal entity US Meds) is a privately held US software vendor that operates a cloud-based data exchange platform purpose-built for pharmaceutical supply chain DSCSA compliance. The platform is structured around a three-step workflow — Prepare (converting serialized inventory into EPCIS-ready transaction information), Exchange (transmitting EPCIS data between trading partners using standardized protocols), and Monitor (tracking transaction status and identifying transmission exceptions) — and is designed to integrate with customers' existing ERP, WMS, serialization, and pharmacy management systems rather than replacing them. Core proprietary capabilities include EPCIS data exchange infrastructure, trading partner onboarding and connectivity management, transaction monitoring, and notably support for repackaging transformation events that most general-purpose supply chain systems do not natively handle. The company serves four vertical segments within the pharmaceutical supply chain: wholesale distributors, repackagers, manufacturers, and physician dispensers, with named customers including DocRx, NuCare, HN Pharma Inc, and QuantumPharmRX.

USMeds monetizes through enterprise SaaS subscriptions on an annual billing cadence with quote-based pricing tied to organization size and trading partner network volume, supported by a direct enterprise field sales motion gated behind a "Request a Demo" funnel. The marketing mix is content-driven, centered on a DSCSA education blog with supporting organic presence on LinkedIn and Facebook, plus dedicated industry landing pages for each target vertical. The company is privately held with no disclosed funding, headcount, leadership team, M&A activity, or revenue figures, and operates exclusively in the US market (single-country, domestic scope).

Name

USMeds Pedigree Systems

Legal name

US Meds

Website

https://usmeds.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

USMeds Pedigree Systems operates a cloud-based EPCIS data exchange platform that enables pharmaceutical wholesale distributors, repackagers, manufacturers, and physician dispensers to maintain serialized product traceability and meet DSCSA compliance requirements across trading partner networks.

Ownership category

akta.pro rank

Product category

Pharmaceutical Supply Chain Compliance Software

NAICS

Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)

Keywords

• DSCSA compliance software
• EPCIS data exchange
• Pharmaceutical traceability
• Supply chain serialization
• Trading partner integration

Headquarters

HQ city

Miami Lakes

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscription: Infrastructure-as-a-service model providing DSCSA compliance and EPCIS data exchange capabilities on a subscription basis. The company offers platform access, support, and ongoing monitoring services.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

USMeds provides a cloud-based DSCSA compliance platform that enables pharmaceutical organizations to exchange EPCIS transaction data with trading partners, maintain serialized traceability, and support regulatory compliance. The platform operates through a three-step workflow — Prepare (generating EPCIS-ready transaction information from serialized inventory), Exchange (secure transmission of EPCIS data using standardized protocols), and Monitor (transaction visibility and exception detection) — and integrates with existing ERP, WMS, serialization, and pharmacy management systems.

Product overview

USMeds provides a cloud-based data exchange platform that enables pharmaceutical organizations to exchange EPCIS transaction data with trading partners, maintain serialized traceability, and support DSCSA compliance. The platform operates as a unified infrastructure solution that manages the complexity of supply chain data exchange through a three-step workflow: Prepare (serialized inventory preparation for EPCIS-ready transaction information), Exchange (secure transmission of EPCIS data between trading partners using standardized protocols), and Monitor (visibility into transaction status and data exchange activity). The platform is designed for multiple pharmaceutical supply chain segments including wholesale distributors, repackagers, physician dispensers, and manufacturers, and integrates with existing ERP, WMS, serialization platforms, pharmacy management, and supply chain systems without requiring replacement of existing technology investments.

Differentiator

Problem solved

Functional benefit

Products and services

• USMeds DSCSA Data Exchange Platform Cloud-based SaaS platform that enables pharmaceutical organizations to exchange EPCIS transaction data with trading partners, maintain serialized traceability, and support DSCSA compliance. Operates through a three-step workflow (Prepare, Exchange, Monitor) and integrates with existing ERP, WMS, serialization, and pharmacy management systems.

Quantifiable outcome

• Organizations managing 40-300+ trading partners can reduce manual work through standardized workflows and automated validation
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Adents: Adents offers serialization and traceability solutions for the pharmaceutical and life sciences industries, with a focus on unit-level tracking and EPCIS data management. It competes directly with USMeds in supporting trading partner connectivity and DSCSA compliance.
• Axway: Axway provides B2B integration and API management platforms that support EPCIS data exchange and pharmaceutical supply chain interoperability. It competes with USMeds at the data exchange infrastructure layer, particularly for larger enterprise customers.
• rfXcel: rfXcel provides pharmaceutical traceability, DSCSA compliance, and serialization management software. It directly competes with USMeds across wholesale, manufacturing, and dispenser segments with comparable EPCIS data exchange capabilities.
• LSPediA: LSPediA specializes in pharmaceutical DSCSA compliance, EPCIS data exchange, and serialization solutions for distributors, manufacturers, and dispensers. It directly competes with USMeds in the same compliance software niche serving mid-market pharma supply chain participants.
• TraceLink: TraceLink is the leading pharmaceutical supply chain serialization and DSCSA compliance platform, offering EPCIS data exchange across thousands of trading partners. It is the most direct competitor to USMeds in serving wholesale distributors and manufacturers with serialized traceability infrastructure.

Emerging players

• Movilitas: Movilitas provides track-and-trace and supply chain visibility solutions for the pharmaceutical industry, focused on serialization and regulatory compliance. It is an emerging player with partially overlapping capabilities to USMeds, particularly in serialization and traceability.
• Zetes: Zetes provides supply chain serialization and traceability solutions with a presence in pharmaceutical compliance. It has partially overlapping capabilities with USMeds in EPCIS data exchange and DSCSA-ready infrastructure, primarily serving European and global customers.

Broad incumbents

• Antares Vision: Antares Vision is a global provider of serialization, traceability, and inspection systems for the pharmaceutical industry. It addresses similar DSCSA compliance needs as USMeds but as a much larger, diversified incumbent with hardware and software offerings.
• Oracle: Oracle offers pharmaceutical supply chain management and serialization solutions as part of its broader application suite. It competes with USMeds at the compliance and traceability layer for large enterprises with existing Oracle investments.
• SAP: SAP provides pharmaceutical supply chain and serialization solutions (including Information Fusion Platform) that handle DSCSA compliance and EPCIS data exchange. It is a broad incumbent that overlaps with USMeds primarily in larger enterprise deployments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about USMeds Pedigree Systems